# Evaluation of Antibody Detection Tests for Visceral Leishmaniasis Diagnosis in Eastern Africa

> **NCT03646981** · — · COMPLETED · sponsor: **Foundation for Innovative New Diagnostics, Switzerland** · enrollment: 704 (actual)

## Conditions studied

- Leishmaniasis, Visceral

## Interventions

- **DEVICE:** Leishmania Ab Rapid Test (CTK, Biotech)

## Key facts

- **NCT ID:** NCT03646981
- **Lead sponsor:** Foundation for Innovative New Diagnostics, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-01
- **Primary completion:** 2021-10-30
- **Final completion:** 2021-12-01
- **Target enrollment:** 704 (ACTUAL)
- **Last updated:** 2022-06-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03646981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03646981, "Evaluation of Antibody Detection Tests for Visceral Leishmaniasis Diagnosis in Eastern Africa". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03646981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*